VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 123 filers reported holding VENTYX BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,122,062 | -6.4% | 5,247,646 | +122.9% | 0.00% | -33.3% |
| Q1 2024 | $12,947,820 | +122.7% | 2,354,149 | 0.0% | 0.00% | +200.0% |
| Q4 2023 | $5,814,748 | -93.9% | 2,354,149 | -13.7% | 0.00% | -95.8% |
| Q3 2023 | $94,738,300 | +5.9% | 2,727,852 | 0.0% | 0.02% | +9.1% |
| Q2 2023 | $89,473,546 | +12.3% | 2,727,852 | +14.7% | 0.02% | +10.0% |
| Q1 2023 | $79,655,764 | +14.9% | 2,377,784 | +12.4% | 0.02% | +5.3% |
| Q4 2022 | $69,342,456 | – | 2,114,744 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 412,225 | $952,240 | 1.81% |
| Octagon Capital Advisors LP | 2,391,114 | $5,523,473 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 3,100,000 | $7,161,000 | 0.73% |
| Opaleye Management Inc. | 1,190,000 | $2,748,900 | 0.63% |
| Sio Capital Management, LLC | 778,924 | $1,799,314 | 0.49% |
| Parkman Healthcare Partners LLC | 1,160,022 | $2,679,651 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,012,749 | $2,339,450 | 0.32% |
| Redmile Group, LLC | 2,164,126 | $4,999,131 | 0.30% |
| WEXFORD CAPITAL LP | 449,046 | $1,037,296 | 0.26% |
| Vestal Point Capital, LP | 1,315,000 | $3,037,650 | 0.23% |